BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18414401)

  • 1. The fibromatosis signature defines a robust stromal response in breast carcinoma.
    Beck AH; Espinosa I; Gilks CB; van de Rijn M; West RB
    Lab Invest; 2008 Jun; 88(6):591-601. PubMed ID: 18414401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.
    Guo X; Zhu SX; Brunner AL; van de Rijn M; West RB
    Breast Cancer Res; 2013 Dec; 15(6):R117. PubMed ID: 24342436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal responses among common carcinomas correlated with clinicopathologic features.
    Chen JL; Espinosa I; Lin AY; Liao OY; van de Rijn M; West RB
    Clin Cancer Res; 2013 Sep; 19(18):5127-35. PubMed ID: 23804424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of stromal signatures in breast carcinoma.
    West RB; Nuyten DS; Subramanian S; Nielsen TO; Corless CL; Rubin BP; Montgomery K; Zhu S; Patel R; Hernandez-Boussard T; Goldblum JR; Brown PO; van de Vijver M; van de Rijn M
    PLoS Biol; 2005 Jun; 3(6):e187. PubMed ID: 15869330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
    Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
    Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.
    Buraschi S; Neill T; Owens RT; Iniguez LA; Purkins G; Vadigepalli R; Evans B; Schaefer L; Peiper SC; Wang ZX; Iozzo RV
    PLoS One; 2012; 7(9):e45559. PubMed ID: 23029096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in stromal signatures in breast and colorectal cancer metastases.
    Webster JA; Beck AH; Sharma M; Espinosa I; Weigelt B; Schreuder M; Montgomery KD; Jensen KC; van de Rijn M; West R
    J Pathol; 2010 Oct; 222(2):158-65. PubMed ID: 20593409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome.
    Myhre S; Mohammed H; Tramm T; Alsner J; Finak G; Park M; Overgaard J; Børresen-Dale AL; Frigessi A; Sørlie T
    PLoS One; 2010 Nov; 5(11):e14002. PubMed ID: 21124964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.
    Andres SA; Wittliff JL
    Endocrine; 2011 Oct; 40(2):212-21. PubMed ID: 21858728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
    Triulzi T; Casalini P; Sandri M; Ratti M; Carcangiu ML; Colombo MP; Balsari A; Ménard S; Orlandi R; Tagliabue E
    PLoS One; 2013; 8(2):e56761. PubMed ID: 23441215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The macrophage colony-stimulating factor 1 response signature in breast carcinoma.
    Beck AH; Espinosa I; Edris B; Li R; Montgomery K; Zhu S; Varma S; Marinelli RJ; van de Rijn M; West RB
    Clin Cancer Res; 2009 Feb; 15(3):778-87. PubMed ID: 19188147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
    Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
    PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.
    Wu JM; Beck AH; Pate LL; Witten D; Zhu SX; Montgomery KD; Allison KH; van de Rijn M; West RB
    Clin Cancer Res; 2011 Feb; 17(3):437-46. PubMed ID: 21098336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal signatures in endometrioid endometrial carcinomas.
    Espinosa I; Catasus L; D' Angelo E; Mozos A; Pedrola N; Bértolo C; Ferrer I; Zannoni GF; West RB; van de Rijn M; Matias-Guiu X; Prat J
    Mod Pathol; 2014 Apr; 27(4):631-9. PubMed ID: 24263966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.
    Symmans WF; Ayers M; Clark EA; Stec J; Hess KR; Sneige N; Buchholz TA; Krishnamurthy S; Ibrahim NK; Buzdar AU; Theriault RL; Rosales MF; Thomas ES; Gwyn KM; Green MC; Syed AR; Hortobagyi GN; Pusztai L
    Cancer; 2003 Jun; 97(12):2960-71. PubMed ID: 12784330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma.
    Porter S; Scott SD; Sassoon EM; Williams MR; Jones JL; Girling AC; Ball RY; Edwards DR
    Clin Cancer Res; 2004 Apr; 10(7):2429-40. PubMed ID: 15073121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
    Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
    Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.
    Makretsov NA; Hayes M; Carter BA; Dabiri S; Gilks CB; Huntsman DG
    Mod Pathol; 2007 Jan; 20(1):84-9. PubMed ID: 17143263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.